SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-10.2
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex10-2.htm

Chunk 5 of 6
Word Count: 893
Character Count: 5379

Document Content:

and/or (vii) termination of any right an Optionholder has to exercise the Option prior to vesting in the shares subject to the Option (i.e., “early exercise”), such that at or following the closing of the Corporate Transaction the Option may only be exercised to the extent it is vested; each case as determined by the Board. 11 —2024 Equity Incentive Plan Acceleration of Vesting. The Board may, in its sole discretion, provide in any Stock Award Agreement or, in the event of a Corporate Transaction, may take such actions as it deems appropriate to provide for the acceleration of the exercisability and vesting in connection with such Corporate Transaction of any or all then-outstanding Stock Awards and shares acquired upon the exercise thereof upon such conditions, including termination of the Participant’s Continuous Service prior to, upon, or following such Corporate Transaction, and to such extent as the Board shall determine.

Cash-Out of Awards. The Board may, in its sole discretion and without the consent of any Participant, determine that, upon
the occurrence of a Corporate Transaction, each or any Stock Award outstanding immediately prior to the Corporate Transaction shall be
canceled in exchange for a payment with respect to each vested share (and each unvested share, if so determined by the Board) of Common
Stock subject to such canceled Stock Award in (i) cash, (ii) stock of the Company or of a corporation or other business entity a party
to the Corporate Transaction, or (iii) other property which, in any such case, shall be in an amount having a Fair Market Value
equal to the Fair Market Value of the consideration to be paid per share of Common Stock in the Corporate Transaction over the exercise
price per share under such Stock Award (the “Spread”). In the event such determination is made by the Board, the Spread
(reduced by applicable withholding taxes, if any) shall be paid to Participants in respect of their canceled Stock Awards as soon as
practicable following the date of the Corporate Transaction and in respect of the unvested portion of their canceled Stock Awards in
accordance with the vesting schedule applicable to such Awards as in effect prior to the Corporate Transaction.

AMENDMENT OF THE PLAN AND STOCK AWARDS

Amendment of Plan. The Board at any time, and from time to time, may amend the Plan. However, except as provided in Section
11 relating to adjustments upon changes in Common Stock, no amendment shall be effective unless approved by the stockholders of the Company
to the extent stockholder approval is required under applicable law.

Contemplated Amendments. It is expressly contemplated that the Board may amend the Plan in any respect the Board deems
necessary or advisable to provide eligible Employees with the maximum benefits provided or to be provided under the provisions of the
Code and the regulations promulgated thereunder relating to Incentive Stock Options and/or to bring the Plan and/or Incentive Stock Options
granted under it into compliance therewith.

No Impairment of Rights. Rights under any Stock Award granted before amendment of the Plan shall not be impaired by any
amendment of the Plan unless (i) the Company requests the consent of the Participant and (ii) the Participant consents in writing.

Amendment of Stock Awards. The Board at any time, and from time to time, may amend the terms of any one or more Stock Awards;
provided, however, that the rights under any Stock Award shall not be impaired by any such amendment unless (i) the Company requests
the consent of the Participant and (ii) the Participant consents in writing. Notwithstanding the foregoing and any other provision of
the Plan to the contrary, the Board may, in its sole and absolute discretion and without the consent of any Participant, amend the Plan
or any Stock Award Agreement, to take effect retroactively or otherwise, as it deems necessary or advisable for the purpose of conforming
the Plan or such Stock Award Agreement to any present or future law, regulation or rule applicable to the Plan, including, but not limited
to, Section 409A of the Code.

TERMINATION OR SUSPENSION OF THE PLAN

Plan Term. The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate
on the day before the tenth (10th) anniversary of the date the Plan is adopted by the Board or approved by the stockholders of the Company,
whichever is earlier. No Stock Awards may be granted under the Plan while the Plan is suspended or after it is terminated.

No Impairment of Rights. Suspension or termination of the Plan shall not impair rights and obligations under any Stock
Award granted while the Plan is in effect except with the written consent of the Participant.

EFFECTIVE DATE OF PLAN. The Plan shall become effective as determined by the Board,
but no Stock Award shall be exercised (or, in the case of a Restricted Stock Award, shall be granted) unless and until the Plan has been
approved by the stockholders of the Company, which approval shall be within twelve (12) months before or after the date the Plan is adopted
by the Board.

CHOICE OF LAW. The law of the State of Delaware shall govern all questions concerning
the construction, validity and interpretation of this Plan, without regard to such state’s conflict of laws rules.

12 —2024 Equity Incentive Plan